SCHEMBL4607541

SCHEMBL4607541

FC(F)(F)Oc1[c]ccc(I)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL622940 0.78 GPR3 (0.41)
SCHEMBL899948 0.78 GPR3 (0.36)
SCHEMBL1067464 0.76 GPR3 (0.38)
SCHEMBL1068587 0.76 CES2 (0.32)
SCHEMBL22683446 0.76 AURKA (0.32)
SCHEMBL407749 0.76 P2RX1 (0.33)
SCHEMBL455599 0.76 MAOA (0.31)
SCHEMBL6599937 0.76 TSHR (0.32)
SCHEMBL1068187 0.73 PDE2A (0.30)
SCHEMBL1066850 0.73 NPC1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106660991-A Antiproliferative compounds and methods of use thereof 细胞基因公司 2017-05-10 CN disclosed
CN-102753522-B Substituted pyrrolidine-2-carboxamides HOFFMANN LA ROCHE 2013-11-27 CN disclosed
US-20080292608-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2008-11-27 US disclosed
EP-1945633-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2008-07-23 EP disclosed
WO-2007056497-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-05-18 WO disclosed